Recruiting
Phase 1
Phase 2

A Study of PBFT02 in Patients With Frontotemporal Dementia and Progranulin Mutations (FTD-GRN)

Sponsor:

Passage Bio, Inc.

Code:

NCT04747431

Conditions

Frontotemporal Dementia

FTD

FTD-GRN

Dementia Frontotemporal

Eligibility Criteria

Sex: All

Age: 35 - 70+

Healthy Volunteers: Not accepted

Interventions

PBFT02

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information